CareLit Fachartikel
Adherence to tamoxifen therapy after conversion to a discount pharmaceutical in breast cancer patients in Germany
Kostev, K.; May, U.; Handji, P. · Das Gesundheitswesen · 2013 · Heft 8/09 · S. 1 bis 1
Dokument
335651
CareLit-ID
Jahr
2013
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig
Bibliografische Angaben
Zusammenfassung
Background: The aim of this study is to investigate the risk of discontinuing therapy in breast cancer patients treated with tamoxifen both with and without conversion to a discount pharmaceutical (tamoxifen) and to analyse the negative consequences of rebate contracts on the compliance of breast cancer patients among gynaecologist and general practitioner practices in Germany. Methods: This retrospective analysis was performed using the IMS Disease Analyzer® database. Women with a diagnosis of breast cancer and a first time prescription of tamoxifen from January 2008 to December 2011 were selected. The principl…
Schlagworte
Gesundheit
Pflege
Breast
Compliance
Germany
After
Aromatase Inhibitors
Association
Depression
Aromatase
Diagnosis
Database
Betrug
Das Gesundheitswesen
